Skip to main content

and
  1. Article

    Open Access

    Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners

    Complex II (CII) activity controls phenomena that require crosstalk between metabolism and signaling, including neurodegeneration, cancer metabolism, immune activation, and ischemia-reperfusion injury. CII act...

    Pankaj Sharma, Elena Maklashina, Markus Voehler, Sona Balintova in Nature Communications (2024)

  2. No Access

    Protocol

    Spatial Analysis of Nucleotide Metabolism: From CRISPR Knockout Cancer Cells to MALDI Imaging of Tumors

    Cancer cells depend on nucleotides for proliferation. Inhibition of nucleotide metabolism by antimetabolites is a well-established anticancer therapy. However, resistance and toxicity to antimetabolite treatme...

    Petra Hyrossova, Mirko Milosevic, Ahmad Y. Alghadi, Lukas Kucera in Metabolic Reprogramming (2023)

  3. Article

    Open Access

    Generation and characterization of human U-2 OS cell lines with the CRISPR/Cas9-edited protoporphyrinogen oxidase IX gene

    In humans, disruptions in the heme biosynthetic pathway are associated with various types of porphyrias, including variegate porphyria that results from the decreased activity of protoporphyrinogen oxidase IX ...

    Zora Novakova, Mirko Milosevic, Zsofia Kutil, Marketa Ondrakova in Scientific Reports (2022)

  4. No Access

    Protocol

    In Vitro Reconstitution of Molecular Motor-Driven Mitochondrial Transport

    Intracellular trafficking of organelles driven by molecular motors underlies essential cellular processes. Mitochondria, the powerhouses of the cell, are one of the major cargoes of molecular motors. Efficient...

    Verena Puttrich, Jakub Rohlena, Marcus Braun, Zdenek Lansky in Axonal Transport (2022)

  5. No Access

    Article

    SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy

    Pancreatic cancer is one of the deadliest forms of cancer, which is attributed to lack of effective treatment options and drug resistance. Mitochondrial inhibitors have emerged as a promising class of anticanc...

    Zuzana Ezrova, Zuzana Nahacka, Jan Stursa, Lukas Werner, Erik Vlcak in Oncogene (2021)

  6. Article

    Open Access

    Mitochondria-adaptor TRAK1 promotes kinesin-1 driven transport in crowded environments

    Intracellular trafficking of organelles, driven by kinesin-1 step** along microtubules, underpins essential cellular processes. In absence of other proteins on the microtubule surface, kinesin-1 performs mic...

    Verena Henrichs, Lenka Grycova, Cyril Barinka, Zuzana Nahacka in Nature Communications (2020)

  7. Article

    Open Access

    Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors

    p53-mutated tumors often exhibit increased resistance to standard chemotherapy and enhanced metastatic potential. Here we demonstrate that inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme of th...

    Sona Hubackova, Eliska Davidova, Stepana Boukalova in Cell Death & Disease (2020)

  8. Article

    Open Access

    Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2

    Cellular senescence is a form of cell cycle arrest that limits the proliferative potential of cells, including tumour cells. However, inability of immune cells to subsequently eliminate senescent cells from th...

    Sona Hubackova, Eliska Davidova, Katerina Rohlenova in Cell Death & Differentiation (2019)

  9. Article

    Open Access

    Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints

    Cell growth and survival depend on a delicate balance between energy production and synthesis of metabolites. Here, we provide evidence that an alternative mitochondrial complex II (CII) assembly, designated a...

    Ayenachew Bezawork-Geleta, He Wen, LanFeng Dong, Bing Yan in Nature Communications (2018)

  10. No Access

    Chapter

    Mitocans: Mitochondrially Targeted Anti-cancer Drugs

    Mitochondria are intriguing organelles that are inherently present in most eukaryotic cells, with notable exceptions. They undertake multiple vital functions in a cell, including energy conversion, metabolite ...

    Stepana Boukalova, Katerina Rohlenova in Mitochondrial Biology and Experimental The… (2018)

  11. No Access

    Protocol

    Evaluation of Respiration of Mitochondria in Cancer Cells Exposed to Mitochondria-Targeted Agents

    Respiration is one of the major functions of mitochondria, whereby these vital organelles use oxygen to produce energy. Many agents that may be of potential clinical relevance act by targeting mitochondria, wh...

    Katarina Kluckova, Lan-Feng Dong, Martina Bajzikova in Mitochondrial Medicine (2015)

  12. No Access

    Chapter

    Mitochondrial Complex II in Cancer

    The mitochondrial connection in cancer has long been suspected, but the first unequivocal genetic link was established only when hereditary paraganglioma-associated mutations were found in genes coding for the...

    Katarina Kluckova, Jiri Neuzil in Mitochondria: The Anti- cancer Target for … (2014)

  13. Article

    K-Ras and mitochondria: Dangerous liaisons

    It is well documented that the K-RAS oncogene efficiently transforms non-malignant cells, and there is some evidence for the role of mitochondria in this process. Now Peng Huang and colleagues show that K-Ras ind...

    Jiri Neuzil, Jakub Rohlena, Lan-Feng Dong in Cell Research (2012)